Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SXTC

China SXT Pharmaceuticals (SXTC)

China SXT Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SXTC
DateTimeSourceHeadlineSymbolCompany
15/05/202406:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SXTCChina SXT Pharmaceuticals Inc
12/01/202408:31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SXTCChina SXT Pharmaceuticals Inc
27/10/202307:05GlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price RuleNASDAQ:SXTCChina SXT Pharmaceuticals Inc
04/10/202323:30GlobeNewswire Inc.China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock SplitNASDAQ:SXTCChina SXT Pharmaceuticals Inc
01/08/202306:15Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:SXTCChina SXT Pharmaceuticals Inc
20/05/202307:17Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
10/05/202322:00GlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price RuleNASDAQ:SXTCChina SXT Pharmaceuticals Inc
30/03/202305:20Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
30/03/202304:50Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
27/03/202321:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(7) (424b7)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
01/03/202308:06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
25/02/202309:20Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
14/02/202308:29Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
23/12/202222:05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
08/11/202200:00GlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price DeficiencyNASDAQ:SXTCChina SXT Pharmaceuticals Inc
12/10/202223:46Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
27/09/202222:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
19/07/202201:02Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
19/05/202202:30GlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share SplitNASDAQ:SXTCChina SXT Pharmaceuticals Inc
14/05/202206:09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
12/05/202206:06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
25/03/202207:32Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
17/03/202207:06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
16/03/202223:01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
16/03/202207:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
15/03/202213:33GlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 MillionNASDAQ:SXTCChina SXT Pharmaceuticals Inc
22/01/202209:01Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
21/01/202222:05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
21/01/202203:25Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
21/01/202202:45GlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-AllotmentNASDAQ:SXTCChina SXT Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SXTC